Webinars Interior Header 1457
Webinars Interior Header 1457
Webinars Interior Header 1457

Reinforcing the use of antigen testing to slow the COVID-19 pandemic

Lessons learned from the epicenter Lessons learned from the epicenter Lessons learned from the epicenter

Monday, January 17, 2022
8:00-9:30 AM CT / 3:00-4:30 PM CET

With a focus on new variants and global surges in COVID-19 cases, the world remains on guard to respond to new guidance and potential lockdowns.

Ongoing epidemiological updates on new cases in the unvaccinated, breakthrough infections in the vaccinated, and re-infections in recovered patients have been important guideposts for action.

The diagnosis of COVID-19 includes two approaches - identifying those infected with COVID-19 and identifying those who are infectious with competent virus.

Join this webinar to hear global experts discuss the benefits, latest studies, and rationale for large-scale use of antigen testing as an essential and effective tool in our global testing arsenal.


Michael Mina, MD, PhD — USA
Topic: Re-calibration in the use of Ag test in the fight against the COVID-19 epidemic.

Mary Rodgers, PhD — USA
Topic: The Abbott Global Surveillance Program- SARS-CoV-2 variant vigilance.

Amilcar Tanuri, MD, PhD — Brazil
Topic: High correlation of Virological confirmation on subject infected with COVID-19 when the Ag test is positive.


Luis Gonzalez, MD, PhD
Global Director of Medical and Scientific Affairs - Abbott


Norman Moore, PhD 
Global Director of Scientific Affairs, Infectious Diseases - Abbott

Related Webinars

©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.